Michael Braun is a member of the New York corporate group which he headed for 10 years through 2011. He is also the co-chair of the Japan Practice Group. Mr. Braun is a transactional attorney whose practice focuses on U.S.-based transactional and advisory work, mostly on behalf of Asian and European companies, including many Japanese companies.

Mr. Braun represents some of Japan's largest companies in their U.S. transactions, including mergers & acquisitions, joint ventures,collaboration and other strategic alliences and corporate investments. He also works with other foreign-based and U.S. companies interested in securing strategic investments and alliances around the world. Mr. Braun's clients include global aerospace, retail, real estate, printing, food and beverages, and pharmaceutical/biotechnology businesses.

In the last five years, Mr. Braun assisted numerous Japanese companies in the pharmaceutical, life science and technology sectors in connection with their acquisitions in the U.S. of both private and public companies. He also has counseled them regarding numerous venture capital and private investments in emerging companies, focusing on drug delivery, medical devices, and medical diagnostic products as well as new pharmaceutical products.

Mr. Braun is named “Dealmaker of the Week, May 20, 2010” in connection with representing Astellas Pharma in the tender offer for OSI, the first successful unsolicited tender offer by a Japanese company for a U.S. company. Legal 500 2011 cites a client saying Mr. Braun is “one of the best business lawyers we have worked with. He really knows our company, what is important to us and is a passionate advocate.”